Atezolizumab: Phase Ib amended

Roche’s Genentech unit amended an open-label, U.S. Phase Ib trial of IV atezolizumab with and without Revlimid lenalidomide to include arms evaluating atezolizumab with Darzalex daratumumab, with Re...